ARCHIVES

“Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.”

This article is from The Cancer Letter archive.

Vol. 21 No. 29 | July 21, 1995

Download PDF Visit The Full Archive

Related Articles

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006

Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item

May 2, 1980

House Appropriations by Institute

July 8, 1994

Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge?

October 7, 2005

In Brief: Auto Workers Not At Increased risk Of Bladder Cancer, But Truck Drivers Are, New Study Shows

March 11, 1983

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009